(Q41945793)

English

Therapeutic efficacy of chloroquine in Plasmodium vivax from areas with different epidemiological patterns in India and their Pvdhfr gene mutation pattern

scientific article published on 28 February 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

Therapeutic efficacy of chloroquine in Plasmodium vivax from areas with different epidemiological patterns in India and their Pvdhfr gene mutation pattern (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

Plasmodium vivax

0 references

0 references

0 references

Surendra K. Prajapati

object named as

Surendra Kumar Prajapati

6

0 references

1

object named as

Neena Valecha

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

author name string

Hema Joshi

2

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

Alex Eapen

3

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

John Ravinderan

4

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

Ashwani Kumar

5

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

Pascal Ringwald

7

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

publication date

28 February 2006

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

Transactions of the Royal Society of Tropical Medicine and Hygiene

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

100

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

831-837

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

Plasmodium falciparum isolates in India exhibit a progressive increase in mutations associated with sulfadoxine-pyrimethamine resistance

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.11.012

21 January 2018

Chloroquine resistance in Plasmodium vivax

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.11.012

21 January 2018

Effectiveness of antimalarial drugs

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.11.012

21 January 2018

Chloroquine resistance in Plasmodium vivax: the first case in Brazil

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.11.012

21 January 2018

Vivax malaria resistant to chloroquine: case reports from Bombay

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.11.012

21 January 2018

Dihydrofolate reductase mutations in Plasmodium vivax from Indonesia and therapeutic response to sulfadoxine plus pyrimethamine

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.11.012

21 January 2018

Association of genetic mutations in Plasmodium vivax dhfr with resistance to sulfadoxine-pyrimethamine: geographical and clinical correlates

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.11.012

21 January 2018

Sulfadoxine resistance in Plasmodium vivax is associated with a specific amino acid in dihydropteroate synthase at the putative sulfadoxine-binding site

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.11.012

21 January 2018

An unusual case of multidrug-resistant Plasmodium vivax malaria in Mumbai (Bombay), India.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.11.012

21 January 2018

Vivax malaria resistant to treatment and prophylaxis with chloroquine

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.11.012

21 January 2018

Emergence of chloroquine-resistant Plasmodium vivax in Myanmar (Burma).

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.11.012

21 January 2018

Monitoring the chloroquine sensitivity of Plasmodium vivax from Calcutta and Orissa, India

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.11.012

21 January 2018

Therapeutic responses to different antimalarial drugs in vivax malaria

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.11.012

21 January 2018

Plasmodium vivax resistance to chloroquine?

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.11.012

21 January 2018

Chloroquine-resistant Plasmodium vivax in Papua New Guinea

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.11.012

21 January 2018

Chloroquine-resistant Plasmodium vivax from Indonesia

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.11.012

21 January 2018

Therapeutic efficacies of artesunate-sulfadoxine-pyrimethamine and chloroquine-sulfadoxine-pyrimethamine in vivax malaria pilot studies: relationship to Plasmodium vivax dhfr mutations

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.11.012

21 January 2018

Sulfadoxine-pyrimethamine for the treatment of acute malaria in children of Papua New Guinea. II. Plasmodium vivax

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.11.012

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.TRSTMH.2005.11.012

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41945793&oldid=1930127461"